Dan M. Berger
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Protein Kinase Regulation and GTPase Signaling, Synthesis and biological activity, Quinazolinone synthesis and applications, HER2/EGFR in Cancer Research
Most-Cited Works
- → 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors of Epidermal Growth Factor Receptor Kinase and Their Bioisosteric Relationship to the 4-Anilino-6,7-dialkoxyquinazoline Inhibitors(2000)209 cited
- → Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment(2008)42 cited
- → Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors(2009)35 cited
- → Dramatic Effect of Solvent Hydrogen Bond Basicity on the Regiochemistry of SNAr Reactions of Electron-Deficient Polyfluoroarenes(2009)32 cited
- → Novel pyrazolopyrimidines as highly potent B-Raf inhibitors(2009)30 cited
- → Discovery of highly potent and selective type I B-Raf kinase inhibitors(2009)25 cited
- → Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1(2013)20 cited
- → 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as Potent Src Kinase Inhibitors(2005)16 cited
- → Indazolylpyrazolopyrimidine as Highly Potent B-Raf Inhibitors with in Vivo Activity(2010)16 cited
- → Synthesis and biological evaluation of tricyclic anilinopyrimidines as IKKβ inhibitors(2010)16 cited